FDAnews
www.fdanews.com/articles/195982-soligenix-nabs-fast-track-status-for-rivax

Soligenix Nabs Fast Track Status for RiVax

February 24, 2020

The FDA granted fast track designation for Soligenix’s RiVax (heat stable ricin toxin vaccine) to prevent ricin poisoning.

Ricin toxin is a lethal plant-derived toxin that comes in powder, mist, or pellet forms. The Centers for Disease Control and Prevention estimates that the lethal dose in humans is about the size of a grain of salt.

The company received funding for RiVax from the FDA and the National Institute of Allergy and Infectious Diseases (NIAID).

View today's stories